Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

Article ID	Journal	Published Year	Pages	File Type
3297403	Gastroenterology	2011	11 Pages	PDF

Abstract

Patients with MHE significantly improve driving simulator performance after treatment with rifaximin, compared with placebo.

Keywords

MHE IL-10 NSE DST SIP BDT Neuron-specific enolase digit symbol test inhibitory control test interleukin block design test Minimal hepatic encephalopathy Cirrhosis Driving performance Cognitive function ICT sickness impact profile

Related Topics

Health Sciences Medicine and Dentistry Gastroenterology

Preview

Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

Authors

Jasmohan S. Bajaj, Douglas M. Heuman, James B. Wade, Douglas P. Gibson, Kia Saeian, Jacob A. Wegelin, Muhammad Hafeezullah, Debulon E. Bell, Richard K. Sterling, R. Todd Stravitz, Michael Fuchs, Velimir Luketic, Arun J. Sanyal,